Search - tctmd.com

Displaying 941 - 960 of 1148

Sort: Relevancy | Date

Presentation

Changes to Polymer Surface of Drug-Eluting Stents During Balloon Expansion

Presenter: 167498|Scott Denardo

May 24, 2012

News Daily News

Meta-analysis: Superior Efficacy with DES at No Cost to Safety

May 22, 2012

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Caitlin E. Cox

May 22, 2012

News Conference News EuroPCR 2012

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

Caitlin E. Cox

May 18, 2012

News Conference News EuroPCR 2012

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

Caitlin E. Cox

May 17, 2012

News Conference News EuroPCR 2012

CIBELES: Xience Stands Up to Cypher for CTO PCI

Caitlin E. Cox

May 17, 2012

News Conference News EuroPCR 2012

Strong Showing for Bioabsorbable-Scaffold DES

Caitlin E. Cox

May 16, 2012

News Industry News

Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries

May 16, 2012

News Industry News

One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent

May 15, 2012

News Industry News

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

May 15, 2012

News Industry News

Abbott's XIENCE PRIME™ and XIENCE V® Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy

May 15, 2012

News Conference News

Study Examines Influence of Baseline Factors on Outcomes After CABG, PCI

L.A. McKeown

May 11, 2012

News Daily News

Early Exercise Stress Testing After Primary PCI Simple, Safe, Economical

May 10, 2012

News Industry News

Clinical Data for OrbusNeich’s Combo Dual Therapy Stent™ Set for Presentation at EuroPCR 2012

May 08, 2012

News Daily News

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

L.A. McKeown

April 25, 2012

Presentation Fellows 2012

Next-Generation Technologies: Bioabsorbable Stents/Polymers, Drug-Eluting Balloons, and More

Presenter: Juan Granada

April 21, 2012

Presentation Fellows 2012

First-Generation Drug-Eluting Stents: The Good, the Bad, and the Ugly

Presenter: Issam Moussa

April 21, 2012

News Daily News

TRIGGER-PCI Published: Halted Trial Questions Platelet Testing in Stable Patients

April 19, 2012

News Daily News

First Implanted Biodegradable Stent Shows Positive Safety at 10 Years

Jason Kahn

April 17, 2012

News Industry News

Abbott Receives Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent in Japan

April 09, 2012

Advertisement

Changes to Polymer Surface of Drug-Eluting Stents During Balloon Expansion

Meta-analysis: Superior Efficacy with DES at No Cost to Safety

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

CIBELES: Xience Stands Up to Cypher for CTO PCI

Strong Showing for Bioabsorbable-Scaffold DES

Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries

One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

Abbott's XIENCE PRIME™ and XIENCE V® Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy

Study Examines Influence of Baseline Factors on Outcomes After CABG, PCI

Early Exercise Stress Testing After Primary PCI Simple, Safe, Economical

Clinical Data for OrbusNeich’s Combo Dual Therapy Stent™ Set for Presentation at EuroPCR 2012

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

Next-Generation Technologies: Bioabsorbable Stents/Polymers, Drug-Eluting Balloons, and More

First-Generation Drug-Eluting Stents: The Good, the Bad, and the Ugly

TRIGGER-PCI Published: Halted Trial Questions Platelet Testing in Stable Patients

First Implanted Biodegradable Stent Shows Positive Safety at 10 Years

Abbott Receives Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent in Japan

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content